Drawing for EMED SCREEN

USPTO serial 97806709

EMED SCREEN

Reviewed by CopyMark Law Group

Reg. 7560506Status 700Registered
Filing date
Status date
Registration date
Nov 5, 2024
Examiner
XU, ELAINE YILIN
Law office
TMO LAW OFFICE 127

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EMED SCREEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas Y. Yee

Thomas Y. Yee Perkins Coie LLPP.O. Box 2608Seattle, WA 98111United States

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic kits consisting primarily of reagents and antibodies to detect drugs for drug screening except for medical or veterinary use; Rapid drug screening tests comprised of diagnostic and chemical reagents for the simultaneous, qualitative detection of multiple drugs and metabolites, not for medical or veterinary purposesACTIVEMar 1, 2023
005Diagnostic preparations for medical purposes; test kits for diagnostic purposes, namely, medical diagnostic test strips for use in the field of the detection of drugs; rapid drug screening tests comprised of diagnostic and chemical reagents for the simultaneous, qualitative detection of multiple drugs and metabolites, for medical purposesACTIVEMar 1, 2023
042Providing on-line, non-downloadable internet-based software for use in detecting, screening and monitoring the presence of drugs; providing temporary use of on-line, non-downloadable cloud-based software for use in detecting, screening and monitoring the presence of drugs; software as a service (SAAS) services featuring software for use in detecting, screening and monitoring the presence of drugs; platform as a service (PAAS) featuring computer software platforms for detecting, screening, and monitoring the presence of drugs; providing on-line, non-downloadable internet-based software for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; providing on-line, non-downloadable cloud-based software for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; software as a service (SAAS) services featuring software for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; platform as a service (PAAS) featuring computer software platform for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; software as a service (SAAS) services featuring software for providing a non-downloadable online platform that enables video conferencing connectivity between proctors and users; software as a service (SAAS) services featuring software for live digital communications, namely, live video and audio conferencing with multiple simultaneous users, teleconferencing, and network conferencing; software as a service (SAAS) services featuring software for providing a non-downloadable online platform to enable workflow management of a proctored examination; software as a service (SAAS) services featuring software for providing a non-downloadable online platform to enable video conferencing connectivity between proctors and users to conduct a proctored test; platform as a service (PAAS) featuring computer software platforms for proctoring of exams; platform as a service (PAAS) featuring computer software platforms for providing online identity verification services and for creating identity verification reports; platform as a service (PAAS) featuring computer software platforms for providing process verification services for businesses and for creating process verification reports; providing temporary use of non-downloadable cloud based software as a service (SAAS) services, comprising AI-enabled proctoring to ensure integrity of remote assessments with real-time image, audio, and video proctoring, assessing functional, programming, technical and communication skills in real-time with video interviews, preventing cheating using AI, and conducting video interviews; software as a service (SAAS) services featuring software for secure exam proctoring and content protection, identification verification, and data analytics associated therewith; software as a service (SAAS) services featuring software for providing proctored examination testing, examination monitoring, and for reporting examination and testing results to government agencies, insurers, employers, companies, and users; providing temporary use of on-line non-downloadable cloud-based computer software for autonomous online proctoring and identity verification; providing temporary use of online non-downloadable software for enabling video conferencing connectivity between proctors and users; software as a service (SAAS) services featuring software for providing a non-downloadable online platform that enables users to order diagnostic tests, to take diagnostic tests online with the guidance of a proctor, to view and access test results, and to order pharmaceuticals and prescriptions; software as a service (SAAS) services featuring software for providing a non-downloadable online platform that enables AI-based guidance through self-administered diagnostic tests; software as a service (SAAS) services featuring software for providing an online platform that enables users to access digital health results; Providing document and identity verification services, namely, providing remote identity document scanning being electronic scanning of personally identifying photographic images, photo scanning, digitization of documents, data extraction being data encryption, data decryption, all of the foregoing in the field of authentication and verification services being provided via a website; computer security services in the nature of screening of individuals by administering digital certificates for personal identity verification services provided through digital identification technology to authenticate user identity; Screening of individuals in the nature of using video to verify personal identity of users to authenticate user identity of test takers; Screening of individuals in the nature of using a personalized code to verify personal identity of users to authenticate user identity of test takers; screening of individuals in the nature of providing non-downloadable mobile access and web-based platforms featuring technology for personal identity verification to authenticate user identity; providing user authentication of personal identifying information using single sign-on technology via secure storage and transmission of supporting evidence via the internet for use with online software applications; providing user authentication services for personal identifying information using single-sign on technology via video conference for use with online software applications; none of the foregoing for use in emergency medicine and none of the foregoing for training medical professionalsACTIVEMar 1, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 5, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 5, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 27, 2024SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 27, 2024CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 23, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 23, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 28, 2024IUAFUSE AMENDMENT FILED—
Jun 28, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 25, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 19, 2024ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Feb 6, 2024ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 9, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 9, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 20, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 4, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 4, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Dec 4, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 4, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 4, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 3, 2023DOCKASSIGNED TO EXAMINER—
Nov 3, 2023DOCKASSIGNED TO EXAMINER—
Oct 31, 2023DOCKASSIGNED TO EXAMINER—
Apr 10, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 10, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 10, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 10, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 10, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 14, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 25, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance